Hospital for Special Surgery Celebrates its 150th Anniversary By Ringing The Closing Bell at the NYSE
New York—June 17, 2013
Executives and guests of New York’s Hospital for Special Surgery (HSS) visited the New York Stock Exchange (NYSE) to celebrate its 150th anniversary and to ring The NYSE Closing Bell. Louis A. Shapiro, President and CEO, was joined on the podium by Kendrick R. Wilson, III, HSS Co-Chair Board of Trustees and member of BlackRock’s Global Executive Committee, and Dean R. O’Hare, HSS Co-Chair Board of Trustees and Retired Chairman and CEO of The Chubb Corporation. Also joining were Thomas Lister, Vice Chair; Thomas P. Sculco, MD, Surgeon-in-Chief; Mary K. Crow, MD, Physician-in-Chief; Steven R. Goldring, MD, Chief Scientific Officer; Bruce Slawitsky, Vice President of Human Resources and Service Excellence; and Christine Carey, CIS Project Specialist, Information Technology and 2012 Employee of the Year.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics for 14 years in a row and No. 2 in rheumatology by U.S.News & World Report (2023-2024). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In addition, HSS opened a new facility in Florida in early 2020. In 2019, HSS provided care to 151,000 patients and performed more than 35,000 surgical procedures, and people from all 50 U.S. states and 89 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 translational research laboratories, 33 scientists, 10 clinician-scientists, 55 clinical investigators and 245 scientific support staff that drive the HSS research enterprise in the musculoskeletal “ecosystem,” neurology, pain management and rheumatic diseases. The HSS Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The HSS Education Institute is the world’s leading provider of education on musculoskeletal health, with its online learning platform offering more than 300 courses to more than 30,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.
Need Help Finding a Physician?
+1.877.606.1555
Media Contacts
- Tracy Hickenbottom
- Noelle Carnevale
212.606.1197
mediarelations@hss.edu
Social Media Contacts
More News
